ABBio Overview
- Year Founded
-
2020
- Status
-
Out of Business
- Employees
-
3
- Latest Deal Type
-
Out of Business
ABBio General Information
Description
Developer of antibodies designed for the treatment of oncology and Alzheimer's diseases. The company's technology focuses on a specific range of tumor suppressor gene antibodies developed in research labs, enabling researchers and pharmaceutical companies to use the antibodies as drug targets to counter diseases.
Contact Information
Website
www.abbio.co.ukCorporate Office
- Unit 6, Riverside Court
- Mayo Avenue, Angus
- Dundee DD2 1XD
- Scotland, United Kingdom
Corporate Office
- Unit 6, Riverside Court
- Mayo Avenue, Angus
- Dundee DD2 1XD
- Scotland, United Kingdom
ABBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 07-Jul-2026 | Completed | Out of Business | |||
| 1. Early Stage VC | Completed | Generating Revenue |
ABBio Signals
ABBio Acquisitions (1)
ABBio’s most recent deal was a Merger/Acquisition with Luperacus. The deal was made on 01-Jan-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Luperacus | 01-Jan-2021 | Merger/Acquisition | Drug Discovery |
ABBio FAQs
-
When was ABBio founded?
ABBio was founded in 2020.
-
Where is ABBio headquartered?
ABBio is headquartered in Dundee, United Kingdom.
-
What is the size of ABBio?
ABBio has 3 total employees.
-
What industry is ABBio in?
ABBio’s primary industry is Drug Discovery.
-
Is ABBio a private or public company?
ABBio is a Private company.
-
What is ABBio’s current revenue?
The current revenue for ABBio is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process